Solvay News
Most Popular Solvay Story
Solvay shelves obesity drug
Solvay took a hard look at its experimental obesity drug and decided that the regulatory hurdles it faces are simply too high. The data for SLV319--in Phase II--"confirmed its clinical activity and... Read more...
Latest Headlines
- November 17, 2008
- June 3, 2008
- February 29, 2008
- September 14, 2007
- August 30, 2007
- August 27, 2007
- August 13, 2007
- January 30, 2007
- January 23, 2007
- January 21, 2007
- January 10, 2007
- December 7, 2006
- November 28, 2005
- November 21, 2005
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
